[HTML][HTML] Tumor immune microenvironment and its related miRNAs in tumor progression
Y Xing, G Ruan, H Ni, H Qin, S Chen, X Gu… - Frontiers in …, 2021 - frontiersin.org
MiRNA is a type of small non-coding RNA, by regulating downstream gene expression that
affects the progression of multiple diseases, especially cancer. MiRNA can participate in the …
affects the progression of multiple diseases, especially cancer. MiRNA can participate in the …
[HTML][HTML] Recent advances in molecular mechanisms of cancer immunotherapy
Simple Summary The cancer-immunity cycle is characterized by various stimulatory and
inhibitory factors, which together regulate the immune response and halt the extreme …
inhibitory factors, which together regulate the immune response and halt the extreme …
[HTML][HTML] The immune landscape of breast cancer: strategies for overcoming immunotherapy resistance
K Retecki, M Seweryn, A Graczyk-Jarzynka, M Bajor - Cancers, 2021 - mdpi.com
Simple Summary Immunotherapy is a rapidly advancing field in breast cancer treatment,
however, it encounters many obstacles that leave open gateways for breast cancer cells to …
however, it encounters many obstacles that leave open gateways for breast cancer cells to …
[HTML][HTML] The role of miRNA in tumor immune escape and miRNA-based therapeutic strategies
Z Zhang, Q Huang, L Yu, D Zhu, Y Li, Z Xue… - Frontiers in …, 2022 - frontiersin.org
Tumor immune escape is a critical step in the malignant progression of tumors and one of
the major barriers to immunotherapy, making immunotherapy the most promising …
the major barriers to immunotherapy, making immunotherapy the most promising …
[HTML][HTML] Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome
Hepatocellular carcinoma (HCC) is the second most lethal cancer and a leading cause of
cancer-related mortality worldwide. Immune checkpoint inhibitors (ICIs) significantly …
cancer-related mortality worldwide. Immune checkpoint inhibitors (ICIs) significantly …
[HTML][HTML] Breast cancer drug resistance: overcoming the challenge by capitalizing on MicroRNA and tumor microenvironment interplay
G Cosentino, I Plantamura, E Tagliabue, MV Iorio… - Cancers, 2021 - mdpi.com
Simple Summary The cross-talk between neoplastic cells and microenvironment is known to
play a crucial role in tumor development as well as in the phenomenon of resistance to …
play a crucial role in tumor development as well as in the phenomenon of resistance to …
PD-1/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs
M Ashrafizadeh, A Zarrabi, K Hushmandi, V Zarrin… - Life sciences, 2020 - Elsevier
Cancer immunotherapy is a growing field nowadays. Among different molecular pathways,
PD-1/PD-L1 signaling pathway plays a significant role in the regulation of immune …
PD-1/PD-L1 signaling pathway plays a significant role in the regulation of immune …
[HTML][HTML] Peptide-based vaccines in clinical phases and new potential therapeutic targets as a new approach for breast cancer: a review
ML Nicolas-Morales, A Luisa-Sanjuan… - Vaccines, 2022 - mdpi.com
Breast cancer is the leading cause of death in women from 20 to 59 years old. The
conventional treatment includes surgery, chemotherapy, hormonal therapy, and …
conventional treatment includes surgery, chemotherapy, hormonal therapy, and …
Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines
Breast cancer (BC) is one of the prevalent cancers among women. Generally, the treatment
of BC is mostly based on several prominent strategies, including chemotherapy, surgery …
of BC is mostly based on several prominent strategies, including chemotherapy, surgery …
A novel engineered AAV-based neoantigen vaccine in combination with radiotherapy eradicates tumors
KCY Huang, CY Lai, WZ Hung, HY Chang, PC Lin… - Cancer Immunology …, 2023 - AACR
The potency of tumor-specific antigen (TSA) vaccines, such as neoantigen (neoAg)-based
cancer vaccines, can be compromised by host immune checkpoint inhibitory mechanisms …
cancer vaccines, can be compromised by host immune checkpoint inhibitory mechanisms …